Intended Audience: All neonatal nurses

NCC Category Codes: NIC 2, NNP 2

Objectives: Upon completion, learners will be able to:

Outline the process of hematopoiesis in the fetus and newborn.
Describe the pathophysiology of TMD.
List the symptoms of TMD.
Discuss the management of TMD.

Purpose of this CE Activity: The purpose of this article is to examine the literature and
report on the pathophysiology, diagnosis, possible symptoms, complications, management, and life span implications of
transient myeloproliferative disorder.

Requirements for Completion: The following requirements are necessary for successful completion of this CNE activity.

Access to a computer with an Internet connection
Pass the posttest with a score of 80%
Complete and submit the evaluation for this CNE activity

Accreditation
Provider, Academy of Neonatal Nursing, approved by the California Board of Registered Nursing, Provider #CEP 6261; and Florida Board of Nursing, Provider #FBN 3218, content code 2505.

The Academy of Neonatal Nursing is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

Release Date: May/June 2019
Review Date: June 30, 2022
Expiration Date: June 30, 2024

Disclosures:

This CNE activity has been reviewed by the Lead Nurse Planner. It has been determined that the material presented here shows no bias.
The content of this CNE activity has been developed by the planning committee and has been reviewed by the Lead Nurse Planner.

Disclaimer: The Academy of Neonatal Nursing assumes no responsibility or liability for the content presented. Care of the infant should always be individualized and no one source relied upon for information regarding aspects of care. Accredited status does not imply endorsement by ANN, ANA, or the American Nurses Credentialing Center of any commercial products displayed or discussed in conjunction with an educational activity.

Larissa Gallaway BSN, RN-NIC

Appearances